ClinicalTrials.Veeva

Menu

Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Iron-deficiency
Hypersensitivity Reactions

Treatments

Other: collection of patient data

Study type

Observational

Funder types

Other

Identifiers

NCT04359368
2019-01266 sp20Steveling3;

Details and patient eligibility

About

This study aims to evaluate characteristics of patients with previous hypersensitivity reaction grades I-IV to intravenous ferric carboxymaltose (Ferinject) or to iron sucrose (Venofer) including age, atopy status, previous allergic reactions, previous medical history, current medications and co-morbidities. Furthermore, symptoms on reaction such as severity grade of reaction will be evaluated.

Enrollment

42 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants from 16 years of age and older with previous hypersensitivity reaction grades I-IV to intravenous ferric carboxymaltose (Ferinject) or to iron sucrose (Venofer).

Exclusion criteria

  • No previous hypersensitivity reaction to iron preparations or reactions to oral iron preparations.
  • If a rejection to use patient data is documented in patient records, the patient will be excluded from analysis.

Trial design

42 participants in 1 patient group

patients with hypersensitivity reactions to NDIPs
Description:
Patients with previous hypersensitivity reaction grades I-IV to intravenous ferric carboxymaltose (Ferinject) or to iron sucrose (Venofer)
Treatment:
Other: collection of patient data

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems